Evidence map›Paper›PMID 35793924›Full record

ArticleBMJ open2022

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.

Ruwan Ratnayake, Nicolas Peyraud, Iza Ciglenecki, Etienne Gignoux, Maria Lightowler, Andrew S Azman, Primitive Gakima, Jean Patrick Ouamba, Joseph Amadomon Sagara, Rollin Ndombe and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07685574 (Case-area Targeted Interventions), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07685574 narecruitingnot on this mapstarted 2024, after this paper: background citation

Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2024 to 2029Enrolled68,400ConditionsCholera, Methodology StudyArmsCholvax
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ruwan RatnayakeInfectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK ruwan.ratnayake@lshtm.ac.uk.ORCID 0000-0003-4978-6668
Nicolas PeyraudMédecins Sans Frontières, Geneva, Switzerland.
Iza CigleneckiMédecins Sans Frontières, Geneva, Switzerland.
Etienne GignouxEpicentre, Paris, France.ORCID 0000-0003-3930-2770
Maria LightowlerEpicentre, Paris, France.
Andrew S AzmanMédecins Sans Frontières, Geneva, Switzerland.
Primitive GakimaMedecins Sans Frontieres, Kinshasa and Goma, Congo.
Jean Patrick OuambaMedecins Sans Frontieres, Kinshasa and Goma, Congo.
Joseph Amadomon SagaraMedecins Sans Frontieres, Kinshasa and Goma, Congo.
Rollin NdombeMedecins Sans Frontieres, Kinshasa and Goma, Congo.
Nana MimbuEpicentre, Paris, France.
Alexandra AscorraEpicentre, Paris, France.
Epicentre and MSF CATI Working Group
Placide Okitayemba WeloProgramme National d'Elimination du Choléra et de lutte contre les autres Maladies Diarrhéiques, Kinshasa, Congo (the Democratic Republic of the).
Elisabeth Mukamba MusengaProgramme Élargie de Vaccination, Kinshasa, Congo (the Democratic Republic of the).
Berthe MiwandaInstitut National de Recherche Biologique, Kinshasa, Congo (the Democratic Republic of the).
Yap BoumEpicentre, Yaoundé, Cameroon.
Francesco ChecchiInfectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
W John EdmundsInfectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Francisco LuqueroEpicentre, Paris, France.
Klaudia PortenEpicentre, Paris, France.
Flavio FingerEpicentre, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCholera outbreaks in fragile settings are prone to rapid expansion. Case-area targeted interventions (CATIs) have been proposed as a rapid and efficient response strategy to halt or substantially reduce the size of small outbreaks. CATI aims to deliver synergistic interventions (eg, water, sanitation, and hygiene interventions, vaccination, and antibiotic chemoprophylaxis) to households in a 100-250 m 'ring' around primary outbreak cases. METHODS AND ANALYSIS: We report on a protocol for a prospective observational study of the effectiveness of CATI. Médecins Sans Frontières (MSF) plans to implement CATI in the Democratic Republic of the Congo (DRC), Cameroon, Niger and Zimbabwe. This study will run in parallel to each implementation. The primary outcome is the cumulative incidence of cholera in each CATI ring. CATI will be triggered immediately on notification of a case in a new area. As with most real-world interventions, there will be delays to response as the strategy is rolled out. We will compare the cumulative incidence among rings as a function of response delay, as a proxy for performance. Cross-sectional household surveys will measure population-based coverage. Cohort studies will measure effects on reducing incidence among household contacts and changes in antimicrobial resistance. ETHICS AND DISSEMINATION: The ethics review boards of MSF and the London School of Hygiene and Tropical Medicine have approved a generic protocol. The DRC and Niger-specific versions have been approved by the respective national ethics review boards. Approvals are in process for Cameroon and Zimbabwe. The study findings will be disseminated to the networks of national cholera control actors and the Global Task Force for Cholera Control using meetings and policy briefs, to the scientific community using journal articles, and to communities via community meetings.

Indexed as

CholeraCross-Sectional StudiesDisease OutbreaksHumansObservational Studies as TopicSanitationVaccinationepidemiologygeographical mappinginfection controlpublic health

Identifiers

PMID35793924
PMCPMC9260795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.